AUROPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > auropharma

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 60.7. According to RSI analysis, auropharma is technically strong. 9.0 AUROPHARMA RSI Chart
MACD (?) MACD: 18.1 and Signal Line: 12.8. According to MACD analysis, auropharma is technically strong. 8.0 AUROPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, auropharma is in a strong uptrend. Major support levels are 823.27, 809.781, 717.087. 10.0 AUROPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, auropharma is in a strong uptrend. Major support levels are 834.5881, 819.3697, 743.8676. 10.0 AUROPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.796. According to bollinger bands, auropharma is technically strong. 7.0 AUROPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 834.1181 and 815.775. Resistance level is 893.5. 6.5 AUROPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 30.3 NA AUROPHARMA Average True Range Chart
Average Directional Index (?) ADX is 22.6 which means AUROPHARMA is in a trading range and there is no trend. NA AUROPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 27, 2020
Open Price 871.0
High Price 893.5
Low Price 862.8
Close Price 868.55
Absolute Change -2.15
Percentage Change -0.247%
Weekly Change 4.22%
Monthly Change 12.4%
Yearly Change 93.2%
52-week high 967.5
52-week low 288.85
Corporate Actions
ExDate Purpose
November 23, 2020 INTDIV - RS 1.25 PER SH
August 21, 2020 AGM/INTDIV-RS1.25 PER SH
August 21, 2020 ANNUAL GENERAL MEETING
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.08
Confidence in Beta3.08%
Market Capital Rs. 50724.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 27 November 2020: Deliverable Quantity:1.76e+06 NA AUROPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 27 November 2020: Daily Volatility:0.6324 NA AUROPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 27 November 2020: PCR_OI:0.559 PCR:0.359 NA AUROPHARMA PCR Chart
Option Pain (?) 27 November 2020: Max Pain:860.0 NA AUROPHARMA Option Pain Chart
Premium (?) 27 November 2020 Premium: 4.6 Futures OI:11516050.0 NA AUROPHARMA Premium Chart
Option_MAX_OI (?) 27 November 2020: Price:868.55 Put with maximum OI:800.0 Call with maximum OI:900.0 NA AUROPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
December 31, 2020 873.15 11516050.0 8739.0 8739.0 868.55
January 28, 2021 877.35 80600.0 152.0 152.0 868.55
February 25, 2021 878.7 0.0 0.0 0.0 868.55

Announcements

November 12, 2020 Record Date Aurobindo Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Nov-2020.
August 13, 2020 Book Closure Aurobindo Pharma Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 25-Aug-2020 to 27-Aug-2020 for the purpose of Dividend.
See all Announcements

Board Meetings

Date Meeting Date Purpose
November 02, 2020 November 11, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended September 30, 2020 and dividend
August 05, 2020 August 12, 2020 Financial Results/Dividend To consider and approve the financial results for the period ended Jun 30, 2020 and dividend
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play